About Jonathan Drachman
Form D filings for Abacus Bioscience in 2023 list Jonathan Drachman as director.
Jonathan Drachman first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jonathan Drachman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jonathan Drachman works with at each company, as listed on that company's latest Form D.
Abacus Bioscience Inc. · Form D, Feb 3, 2023
AW
Alan Wahl
Chief Executive Officer and director
WC
Will Canestero
Director
CL
Che-Leung Law
Director
DH
Diane Hollenbaugh
Director